Loading…

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in t...

Full description

Saved in:
Bibliographic Details
Published in:Amyloid 2018-10, Vol.25 (4), p.215-219
Main Authors: Benson, Merrill D., Buxbaum, Joel N., Eisenberg, David S., Merlini, Giampaolo, Saraiva, Maria J. M., Sekijima, Yoshiki, Sipe, Jean D., Westermark, Per
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393
cites cdi_FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393
container_end_page 219
container_issue 4
container_start_page 215
container_title Amyloid
container_volume 25
creator Benson, Merrill D.
Buxbaum, Joel N.
Eisenberg, David S.
Merlini, Giampaolo
Saraiva, Maria J. M.
Sekijima, Yoshiki
Sipe, Jean D.
Westermark, Per
description The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in this Nomenclature Article. From having recommended the use of the designation "amyloid fibril" for in vivo material only, ISA's nomenclature committee now accepts its use more broadly following the international scientific literature. However, it is important always to stress the origin of the β-fibrils in order to avoid misunderstanding. Given the more broad use of the word "amyloid" several classes of amyloid fibrils may be distinguished. For the medical in vivo situation, and to be included in the amyloid nomenclature list, "amyloid" still means mainly extracellular tissue deposits of protein fibrils, recognized by specific properties, such as green-yellow birefringence after staining with Congo red. It should also be underlined that in vivo amyloid fibrils, in addition to the main protein contain associated compounds, particularly serum amyloid P-component (SAP) and proteoglycans, mainly heparan sulfate proteoglycan. With this definition there are presently 36 human amyloid proteins of which 14 appear only associated with systemic amyloidosis and 19 as localized forms. Three proteins can occur both as localized and systemic amyloidosis. Strictly intracellular aggregates are not included in this list.
doi_str_mv 10.1080/13506129.2018.1549825
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_13506129_2018_1549825</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2164548085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EoqXwE0A-Foks_kwcTl2Vr5UqcShwtSbOGIySeLEdVfvvSdhtJS6cbI2e9xlpXkJecrbhzLC3XGpWc9FuBONmw7VqjdCPyDlvlKqE4ebx8l-YaoXOyLOcfzEmJGvNU3Iml6gSRp6TvB0PQww9neKIkxugzAnp6nxHE7o4LtMeSohTpt2Blp9Id1PBNP2dwUBvowtYDjR6elLFHDK93N1uX_8rXWWhFMTn5ImHIeOL03tBvn388PX6c3Xz5dPuentTOaVZqXrfIW9M7TtgUuoOBEDPa2GatvWtMMZ7aLxQ3nmn-47VjQclWu6gQ2xkKy_Im6M33-F-7uw-hRHSwUYI9n34vrUx_bDzbGVjGrXil0d8n-LvGXOxY8gOhwEmjHO2gtdKK8OMXlB9RF2KOSf0D27O7FqPva_Hrqe0p3qW3KvTirkbsX9I3fexAFdHIEw-phHuYhp6W2A5bPIJJheylf_f8Qf606DT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2164548085</pqid></control><display><type>article</type><title>Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Benson, Merrill D. ; Buxbaum, Joel N. ; Eisenberg, David S. ; Merlini, Giampaolo ; Saraiva, Maria J. M. ; Sekijima, Yoshiki ; Sipe, Jean D. ; Westermark, Per</creator><creatorcontrib>Benson, Merrill D. ; Buxbaum, Joel N. ; Eisenberg, David S. ; Merlini, Giampaolo ; Saraiva, Maria J. M. ; Sekijima, Yoshiki ; Sipe, Jean D. ; Westermark, Per</creatorcontrib><description>The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in this Nomenclature Article. From having recommended the use of the designation "amyloid fibril" for in vivo material only, ISA's nomenclature committee now accepts its use more broadly following the international scientific literature. However, it is important always to stress the origin of the β-fibrils in order to avoid misunderstanding. Given the more broad use of the word "amyloid" several classes of amyloid fibrils may be distinguished. For the medical in vivo situation, and to be included in the amyloid nomenclature list, "amyloid" still means mainly extracellular tissue deposits of protein fibrils, recognized by specific properties, such as green-yellow birefringence after staining with Congo red. It should also be underlined that in vivo amyloid fibrils, in addition to the main protein contain associated compounds, particularly serum amyloid P-component (SAP) and proteoglycans, mainly heparan sulfate proteoglycan. With this definition there are presently 36 human amyloid proteins of which 14 appear only associated with systemic amyloidosis and 19 as localized forms. Three proteins can occur both as localized and systemic amyloidosis. Strictly intracellular aggregates are not included in this list.</description><identifier>ISSN: 1350-6129</identifier><identifier>ISSN: 1744-2818</identifier><identifier>EISSN: 1744-2818</identifier><identifier>DOI: 10.1080/13506129.2018.1549825</identifier><identifier>PMID: 30614283</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>aggregation ; Amyloid ; amyloidosis ; misfolding ; nomenclature ; Pathology ; Patologi</subject><ispartof>Amyloid, 2018-10, Vol.25 (4), p.215-219</ispartof><rights>2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393</citedby><cites>FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30614283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-378749$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Benson, Merrill D.</creatorcontrib><creatorcontrib>Buxbaum, Joel N.</creatorcontrib><creatorcontrib>Eisenberg, David S.</creatorcontrib><creatorcontrib>Merlini, Giampaolo</creatorcontrib><creatorcontrib>Saraiva, Maria J. M.</creatorcontrib><creatorcontrib>Sekijima, Yoshiki</creatorcontrib><creatorcontrib>Sipe, Jean D.</creatorcontrib><creatorcontrib>Westermark, Per</creatorcontrib><title>Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee</title><title>Amyloid</title><addtitle>Amyloid</addtitle><description>The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in this Nomenclature Article. From having recommended the use of the designation "amyloid fibril" for in vivo material only, ISA's nomenclature committee now accepts its use more broadly following the international scientific literature. However, it is important always to stress the origin of the β-fibrils in order to avoid misunderstanding. Given the more broad use of the word "amyloid" several classes of amyloid fibrils may be distinguished. For the medical in vivo situation, and to be included in the amyloid nomenclature list, "amyloid" still means mainly extracellular tissue deposits of protein fibrils, recognized by specific properties, such as green-yellow birefringence after staining with Congo red. It should also be underlined that in vivo amyloid fibrils, in addition to the main protein contain associated compounds, particularly serum amyloid P-component (SAP) and proteoglycans, mainly heparan sulfate proteoglycan. With this definition there are presently 36 human amyloid proteins of which 14 appear only associated with systemic amyloidosis and 19 as localized forms. Three proteins can occur both as localized and systemic amyloidosis. Strictly intracellular aggregates are not included in this list.</description><subject>aggregation</subject><subject>Amyloid</subject><subject>amyloidosis</subject><subject>misfolding</subject><subject>nomenclature</subject><subject>Pathology</subject><subject>Patologi</subject><issn>1350-6129</issn><issn>1744-2818</issn><issn>1744-2818</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><recordid>eNp9kU1v1DAQhi0EoqXwE0A-Foks_kwcTl2Vr5UqcShwtSbOGIySeLEdVfvvSdhtJS6cbI2e9xlpXkJecrbhzLC3XGpWc9FuBONmw7VqjdCPyDlvlKqE4ebx8l-YaoXOyLOcfzEmJGvNU3Iml6gSRp6TvB0PQww9neKIkxugzAnp6nxHE7o4LtMeSohTpt2Blp9Id1PBNP2dwUBvowtYDjR6elLFHDK93N1uX_8rXWWhFMTn5ImHIeOL03tBvn388PX6c3Xz5dPuentTOaVZqXrfIW9M7TtgUuoOBEDPa2GatvWtMMZ7aLxQ3nmn-47VjQclWu6gQ2xkKy_Im6M33-F-7uw-hRHSwUYI9n34vrUx_bDzbGVjGrXil0d8n-LvGXOxY8gOhwEmjHO2gtdKK8OMXlB9RF2KOSf0D27O7FqPva_Hrqe0p3qW3KvTirkbsX9I3fexAFdHIEw-phHuYhp6W2A5bPIJJheylf_f8Qf606DT</recordid><startdate>20181002</startdate><enddate>20181002</enddate><creator>Benson, Merrill D.</creator><creator>Buxbaum, Joel N.</creator><creator>Eisenberg, David S.</creator><creator>Merlini, Giampaolo</creator><creator>Saraiva, Maria J. M.</creator><creator>Sekijima, Yoshiki</creator><creator>Sipe, Jean D.</creator><creator>Westermark, Per</creator><general>Taylor &amp; Francis</general><scope>0YH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope></search><sort><creationdate>20181002</creationdate><title>Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee</title><author>Benson, Merrill D. ; Buxbaum, Joel N. ; Eisenberg, David S. ; Merlini, Giampaolo ; Saraiva, Maria J. M. ; Sekijima, Yoshiki ; Sipe, Jean D. ; Westermark, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>aggregation</topic><topic>Amyloid</topic><topic>amyloidosis</topic><topic>misfolding</topic><topic>nomenclature</topic><topic>Pathology</topic><topic>Patologi</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benson, Merrill D.</creatorcontrib><creatorcontrib>Buxbaum, Joel N.</creatorcontrib><creatorcontrib>Eisenberg, David S.</creatorcontrib><creatorcontrib>Merlini, Giampaolo</creatorcontrib><creatorcontrib>Saraiva, Maria J. M.</creatorcontrib><creatorcontrib>Sekijima, Yoshiki</creatorcontrib><creatorcontrib>Sipe, Jean D.</creatorcontrib><creatorcontrib>Westermark, Per</creatorcontrib><collection>Taylor &amp; Francis Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Amyloid</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benson, Merrill D.</au><au>Buxbaum, Joel N.</au><au>Eisenberg, David S.</au><au>Merlini, Giampaolo</au><au>Saraiva, Maria J. M.</au><au>Sekijima, Yoshiki</au><au>Sipe, Jean D.</au><au>Westermark, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee</atitle><jtitle>Amyloid</jtitle><addtitle>Amyloid</addtitle><date>2018-10-02</date><risdate>2018</risdate><volume>25</volume><issue>4</issue><spage>215</spage><epage>219</epage><pages>215-219</pages><issn>1350-6129</issn><issn>1744-2818</issn><eissn>1744-2818</eissn><abstract>The nomenclature committee of the International Society of Amyloidosis (ISA) meets every second year to discuss and formulate recommendations. The conclusions from the discussion at the XVI International Symposium on Amyloidosis in Kumamoto, Japan, 25-29 March 2018 and afterwards are summarized in this Nomenclature Article. From having recommended the use of the designation "amyloid fibril" for in vivo material only, ISA's nomenclature committee now accepts its use more broadly following the international scientific literature. However, it is important always to stress the origin of the β-fibrils in order to avoid misunderstanding. Given the more broad use of the word "amyloid" several classes of amyloid fibrils may be distinguished. For the medical in vivo situation, and to be included in the amyloid nomenclature list, "amyloid" still means mainly extracellular tissue deposits of protein fibrils, recognized by specific properties, such as green-yellow birefringence after staining with Congo red. It should also be underlined that in vivo amyloid fibrils, in addition to the main protein contain associated compounds, particularly serum amyloid P-component (SAP) and proteoglycans, mainly heparan sulfate proteoglycan. With this definition there are presently 36 human amyloid proteins of which 14 appear only associated with systemic amyloidosis and 19 as localized forms. Three proteins can occur both as localized and systemic amyloidosis. Strictly intracellular aggregates are not included in this list.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>30614283</pmid><doi>10.1080/13506129.2018.1549825</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1350-6129
ispartof Amyloid, 2018-10, Vol.25 (4), p.215-219
issn 1350-6129
1744-2818
1744-2818
language eng
recordid cdi_crossref_primary_10_1080_13506129_2018_1549825
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects aggregation
Amyloid
amyloidosis
misfolding
nomenclature
Pathology
Patologi
title Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T20%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloid%20nomenclature%202018:%20recommendations%20by%20the%20International%20Society%20of%20Amyloidosis%20(ISA)%20nomenclature%20committee&rft.jtitle=Amyloid&rft.au=Benson,%20Merrill%20D.&rft.date=2018-10-02&rft.volume=25&rft.issue=4&rft.spage=215&rft.epage=219&rft.pages=215-219&rft.issn=1350-6129&rft.eissn=1744-2818&rft_id=info:doi/10.1080/13506129.2018.1549825&rft_dat=%3Cproquest_cross%3E2164548085%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-dfbe1786fba0335ba2aad1628799f9288ffa7f24fcfc5db067fa4291cabee7393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2164548085&rft_id=info:pmid/30614283&rfr_iscdi=true